Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03695172 · ClinicalTrials.gov registry record · Phase 4
Comparison of TAP, Anterior QL, or ESP Block for Elective Cesarean Section
A Phase 4 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT03695172 is a Phase 4 study that was terminated before completion, run by Duke University. The registered enrollment target is 12 participants.
The verdict
NCT03695172, a Phase 4 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this prospective single center, randomized study is to determine if ultrasound guided Transversus Abdominis Plane (TAP), Quadratus Lumborum (QL), and Erector Spinae Plane (ESP) blocks decrease opioid consumption in subjects undergoing elective cesarean section.
Interventions
- DRUG Ropivacaine
- PROCEDURE ESP block
- PROCEDURE TAP block
- BIOLOGICAL QL block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-09-12 |
| Est. Completion | 2021-03-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03695172
The ClinicalTrials.gov registry entry for NCT03695172 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ropivacaine is the first listed.
NCT03695172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03695172 about?
NCT03695172 is a clinical study titled "Comparison of TAP, Anterior QL, or ESP Block for Elective Cesarean Section". The purpose of this prospective single center, randomized study is to determine if ultrasound guided Transversus Abdominis Plane (TAP), Quadratus Lumborum (QL), and Erector Spinae Plane (ESP) blocks decrease opioid consumption in subjects undergoing elective cesarean section.
What is the current status of trial NCT03695172?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2019-09-12. Estimated completion is 2021-03-20.
What interventions are being tested in trial NCT03695172?
The interventions under investigation include: Ropivacaine (DRUG), ESP block (PROCEDURE), TAP block (PROCEDURE), QL block (BIOLOGICAL).
Who is sponsoring clinical trial NCT03695172?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.